Impact of Vaccines on Cancer Treatment

Give evidence on this. I'd just like to point out

that I have done, as you

say, I've been in cancer immunotherapy,

I've been in cancer immunotherapy for over three decades,

and, uh, I have made, uh, big advantage- advances in the

treatment of cancer with immunotherapy.

So this sets the scene that I then be- I became

aware in, uh, early '20, uh, two

of my patients who'd been, uh, stable for years, uh,

do mainly melanoma patients. They'd had several different types of

immunotherapy, and in six weeks I saw six

patients relapse with melanoma. They had, uh, they'd been

stable for three to eighteen years.

They felt well, apart from the relapse, and being

investigated. I asked, you know, what was the thing

that was common? And the thing that was common is they'd all

received a booster vaccine from their general

practitioners. Now I know that these cancers

are c- totally controlled by the T-cell response,

so I immediately

suspected the T-cell response was being perturbated

by the cancer. And initial, uh,

investigations showed that this was likely to be true.

However, there was then a paper published by

some p- uh, doctors in Madrid, which, and I quote,

their paper is called The Evidence of Exhausted Lymphocytes

After the Third Anti-SARS COVID 2 Vaccine Dose in

Cancer Patients. I mean, this was absolutely

staggering that they showed across hundreds of patients that you get

this T-cell suppression. Hot on the heels of this were then a

numerous reports that the, uh, following a booster

vaccine, we were getting IgG immunoglobulin

switching, so you converted the immune system from

being

aggressive fighting invaders to one of tolerization.

So therefore, the immune system was tolerating the cancer,

and this was the reason you were starting to see it.

However, it is important at this stage to say

that we were getting

reports after I first reported this of other cancers.

And my initial observation that this was all due to T-cell

suppression started to, um, fade in-

into the, uh, perspective that other a- actors were at work with

the vaccine, as it were. Colorectal cancer was being

reported by my patients, by my, uh, fellow surgeons

as reporting, uh, as, uh, presenting late,

stage four, not stage one or two, and early in, in

patients in their twenties and thirties and forties in a way

that we've not

seen before. And then in my own practice, as I was

looking for patients, uh, w- who had co- um, who'd had

other cancers, I noticed that they too had had

booster vaccines, and I list them in my report.

They go from everything from the common cancers, from breast,

prostate, et cetera, and all the way through to some really

unexpected ones, including glioma and more

recently hematological malignancies.

Now looking at the, uh, literature as to why this,

uh, could be, and I'm involved in pres- uh, two big publications.

One's we accepted prior to,

uh, um, uh, prior to, um, changes. And this shows that there are

remarkable at least a dozen mechanisms where messenger

RNA can insert into the DNA and

activate oncogenes, and more importantly, in the

especially the long term, they can suppress, uh, the

suppressor networks, which means if a cancer is starting to

evolve, it would normally be maintained, uh, controlled,

and, uh, this a- mechanism is being prevented.

And the number of people who've shown this is quite enormous.

So as an oncologist who I started to see that it's

not only my patients now, it's people I know really well who

are going down with cancer, and they're going down more aggressively,

and the treatment is not working nearly as well.

And I'm used to people saying, "Oh, there's no evidence that the cancer's

increasing and that there's anything to do with the vaccine." But

I can assure you from the patients that I have seen, that many have

seen, uh, a dozen doctors before. Not one of

them has ever asked the vaccine history.

So of course they see no evidence. And my full

detailed research into the messenger RNA vaccines, and I was

on the scientific board of a company claimed to be the messenger RNA

vaccine, uh, company for five years.

I left eight years ago. So I know a lot more than the average

clinician.

And ma- myself and others feel that there is no

way you can control this technology and its use for future